Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.01
+0.04294.44%
Post-market: 1.00-0.0100-0.99%19:31 EDT
Volume:82.46K
Turnover:81.48K
Market Cap:15.03M
PE:-1.37
High:1.02
Open:0.9730
Low:0.9560
Close:0.9671
52wk High:2.29
52wk Low:0.7500
Shares:14.88M
Float Shares:12.27M
Volume Ratio:0.37
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.57
PE(LYR):-0.82

Loading ...

BioCardia Gains FDA Path for CardiAMP PMA Approval

TIPRANKS
·
Jun 05

FDA confirms CardiAMP Heart Failure II Trial may support premarket approval

TIPRANKS
·
Jun 05

BioCardia says FDA confirms CardiAMP HF II trial may support PMA for CardiAMP cell therapy in ischemic HFrEF

Reuters
·
Jun 05

FDA Confirms Cardiamp HF Ii May Support Premarket Approval of Cardiamp Cell Therapy for Ischemic Hfref

THOMSON REUTERS
·
Jun 05

BioCardia says Japan PMDA advice clears path for CardiAMP approval filing in ischemic heart failure

Reuters
·
May 28

BioCardia Announces Japan Pmda Record of Advice Supports Regulatory Submission for Approval of Cardiamp Cell Therapy for Ischemic Heart Failure

THOMSON REUTERS
·
May 28

BioCardia CEO Peter Altman acquires common shares worth $1,570.00

Reuters
·
May 22

BioCardia reports CardiAMP trial improves exercise tolerance in chronic myocardial ischemia patients

Reuters
·
May 21

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency

GlobeNewswire
·
May 21

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

GlobeNewswire
·
May 19

BioCardia CEO Peter Altman acquires 5,700 shares valued at $5,244

Reuters
·
May 19

BioCardia Earnings Call: Progress, Promise and Cash Strain

TIPRANKS
·
May 19

BioCardia CEO Peter Altman acquires 5,100 shares for $5,202

Reuters
·
May 16

BioCardia Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

Benzinga Earnings
·
May 15

BioCardia, Inc. Q1 Net Income USD -2.259 Million

Reuters
·
May 15

BioCardia Q1 net loss narrows as expenses decline

Reuters
·
May 15

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Operating Income USD -2.266 Million

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Basic EPS USD -0.21

THOMSON REUTERS
·
May 15